1. Home
  2. NMRA vs NLOP Comparison

NMRA vs NLOP Comparison

Compare NMRA & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • NLOP
  • Stock Information
  • Founded
  • NMRA 2019
  • NLOP N/A
  • Country
  • NMRA United States
  • NLOP United States
  • Employees
  • NMRA N/A
  • NLOP N/A
  • Industry
  • NMRA
  • NLOP
  • Sector
  • NMRA
  • NLOP
  • Exchange
  • NMRA Nasdaq
  • NLOP Nasdaq
  • Market Cap
  • NMRA 424.4M
  • NLOP 428.9M
  • IPO Year
  • NMRA 2023
  • NLOP N/A
  • Fundamental
  • Price
  • NMRA $2.20
  • NLOP $28.94
  • Analyst Decision
  • NMRA Buy
  • NLOP Strong Buy
  • Analyst Count
  • NMRA 8
  • NLOP 1
  • Target Price
  • NMRA $7.57
  • NLOP $46.00
  • AVG Volume (30 Days)
  • NMRA 1.9M
  • NLOP 57.9K
  • Earning Date
  • NMRA 11-06-2025
  • NLOP 11-07-2025
  • Dividend Yield
  • NMRA N/A
  • NLOP 10.69%
  • EPS Growth
  • NMRA N/A
  • NLOP N/A
  • EPS
  • NMRA N/A
  • NLOP N/A
  • Revenue
  • NMRA N/A
  • NLOP $115,901,000.00
  • Revenue This Year
  • NMRA N/A
  • NLOP N/A
  • Revenue Next Year
  • NMRA N/A
  • NLOP N/A
  • P/E Ratio
  • NMRA N/A
  • NLOP N/A
  • Revenue Growth
  • NMRA N/A
  • NLOP N/A
  • 52 Week Low
  • NMRA $0.61
  • NLOP $26.10
  • 52 Week High
  • NMRA $11.57
  • NLOP $34.53
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 41.50
  • NLOP 42.48
  • Support Level
  • NMRA $2.55
  • NLOP $28.75
  • Resistance Level
  • NMRA $2.78
  • NLOP $29.80
  • Average True Range (ATR)
  • NMRA 0.26
  • NLOP 0.44
  • MACD
  • NMRA -0.09
  • NLOP -0.07
  • Stochastic Oscillator
  • NMRA 10.56
  • NLOP 16.56

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.

Share on Social Networks: